Posts Tagged ‘obesity care’

It’s unmistakable. A quick look at the upcoming meeting of the American College of Cardiology in Chicago tells us that obesity care has a growing role in cardiology. The meeting starts March 29 and a total of 27 educational sessions will focus on obesity. Three late breaking publications – two for semaglutide and one for […]

Seemingly limitless demand for obesity meds, botox, and lip fillers is driving robust growth for med spas in the U.S. The medical spa industry reports expansion from 1,600 locations in 2010 to more than 10,000 in 2023. The revenue for an average spa more than doubled to $1.4 million per spa. In 2023, that added […]

ConscienHealth Founder Ted Kyle recently had the opportunity for a conversation about obesity care with Jennifer Pettis of the Gerontological Society of America. It was a time to reflect on the evolution of this care and the challenges that lie ahead. You can listen in on on the GSA Momentum Discussion podcast using the link […]

A new paper in JAMA Network Open documents just how dizzy the pace of change in prescribing for obesity care has been in the last seven years. Prescriptions for obesity medicines have doubled. Phentermine prescribing has grown – it’s generic, cheap, and effective. Even now, it accounts for almost half of obesity medicine prescriptions. But […]

Thankfully, 2024 is behind us now and we have a blank slate for a whole new year ahead of us. But what can we expect? Well, proverbial (probably Danish) wisdom tells us “prediction is difficult, especially if it’s about the future.” Nonetheless, here are our top five predictions about what we will see in 2025 […]

This was a pleasant surprise. For years, the World Health Association avoided the idea that obesity is an actual chronic disease. Today we have evidence for a big shift in thinking. Three senior officials from WHO published a viewpoint in JAMA yesterday to clearly say not only that obesity is a chronic disease, but also […]

Amid a steady stream of news from ObesityWeek, the CDC released new NHANES data this week documenting an ongoing rise in U.S. diabetes prevalence. Between 1999 and 2023, the age-adjusted prevalence of diabetes, diagnosed and undiagnosed, in adults rose from 9.7% to 14.3%. The total prevalence in adults between 2021 and 2023 was 15.8% – […]

We have a lot to think about. Well over 3,000 people spent the better part of the week absorbing new science and insights into obesity – not to mention a momentous election. So as everyone sets about the task of catching up with routines, here is a quick take on five thoughts about what we’re […]

Are we ready for delivering obesity care at the scale necessary to have a meaningful effect on population health? Given the current situation with drug pricing and problems with health insurance, it is easy to think not. But at ObesityWeek in San Antonio, we see people who look past those barriers and find ways to […]

This should not be so hard. New research at ObesityWeek 2024 tells us that chronic care for the chronic disease is truly compelling. Specifically, we are talking about the results of three years of treatment with tirzepatide presented yesterday from the SURMOUNT-1 study. In this study of more than a thousand adults with pre-diabetes, three […]